These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 19795406)
21. Recent advances in abzyme studies. Suzuki H J Biochem; 1994 Apr; 115(4):623-8. PubMed ID: 8089074 [TBL] [Abstract][Full Text] [Related]
22. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site. Seebeck FP; Hilvert D J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871 [TBL] [Abstract][Full Text] [Related]
23. Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models. Di Niro R; Ziller F; Florian F; Crovella S; Stebel M; Bestagno M; Burrone O; Bradbury AR; Secco P; Marzari R; Sblattero D BMC Biotechnol; 2007 Aug; 7():46. PubMed ID: 17678525 [TBL] [Abstract][Full Text] [Related]
24. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies. Johnson G; Moore SW J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205 [TBL] [Abstract][Full Text] [Related]
25. [Sports medicine: Mr Hyde and Dr.Jekyll! ]. Gremion G; Fritschy D Rev Med Suisse; 2009 Aug; 5(212):1539-40. PubMed ID: 19728446 [No Abstract] [Full Text] [Related]
27. Catalytic properties of IgMs with amylolytic activity isolated from patients with multiple sclerosis. Ivanen DR; Kulminskaya AA; Shabalin KA; Isaeva-Ivanova LV; Ershova NA; Saveliev AN; Nevinsky GA; Neustroev KN Med Sci Monit; 2004 Aug; 10(8):BR273-80. PubMed ID: 15277988 [TBL] [Abstract][Full Text] [Related]
28. Intrabody construction and expression. II. A synthetic catalytic Fv fragment. Ohage EC; Wirtz P; Barnikow J; Steipe B J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948 [TBL] [Abstract][Full Text] [Related]
29. Thyroid antibodies in spontaneous autoimmune thyroiditis in the Buffalo rat. Noble B; Yoshida T; Rose NR; Bigazzi PE J Immunol; 1976 Nov; 117(5 Pt 1):1447-55. PubMed ID: 794410 [TBL] [Abstract][Full Text] [Related]
30. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies. Ulrich HD; Schultz PG J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442 [TBL] [Abstract][Full Text] [Related]
31. [Catalytically active antibodies (abzymes) in human milk]. Kit IuIa; Stoĭka RS Ukr Biokhim Zh (1999); 2007; 79(2):5-16. PubMed ID: 18030744 [TBL] [Abstract][Full Text] [Related]
32. [Phenomenon of DNA-abzyme cross-reactivity and its significance for the mechanisms of cytotoxicity and apoptosis]. Suchkov SV; Gabibov AG; Gnuchev NV Ontogenez; 2001; 32(5):348-52. PubMed ID: 11605407 [TBL] [Abstract][Full Text] [Related]
33. Role of complementary proteins in autoimmunity: an old idea re-emerges with new twists. McGuire KL; Holmes DS Trends Immunol; 2005 Jul; 26(7):367-72. PubMed ID: 15927527 [TBL] [Abstract][Full Text] [Related]
34. Expression improvement and mechanistic study of the retro-Diels-Alderase catalytic antibody 10F11 by site-directed mutagenesis. Zheng L; Goddard JP; Baumann U; Reymond JL J Mol Biol; 2004 Aug; 341(3):807-14. PubMed ID: 15288788 [TBL] [Abstract][Full Text] [Related]
35. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog. Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011 [TBL] [Abstract][Full Text] [Related]
37. The rapid discovery of engineered antibodies. Wang M; He M IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332 [TBL] [Abstract][Full Text] [Related]
38. Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies. Wootla B; Rao DN; Friboulet A; Uda T; Lacroix-Desmazes S; Kaveri SV Clin Rev Allergy Immunol; 2009 Oct; 37(2):97-104. PubMed ID: 19160072 [TBL] [Abstract][Full Text] [Related]